Discounted GLP-1 Weight Loss Drugs Now Sold at Walmart, Costco, Sam’s Club, CVS
News

Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS

More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy.
Walmart to Offer Discounted GLP-1 Drugs, Following Costco, Sam’s Club, and CVS
Eli Lilly, Adobe Stock

Discounted cash-pay options for GLP-1 weight loss medications keep expanding — most recently, to Walmart.

Self-pay customers of LillyDirect, the drugmaker Eli Lilly’s online GLP-1 platform, can now choose to pick up discounted vials of Zepbound (tirzepatide) in person at a Walmart pharmacy rather than opting for free home delivery.

Customers must have a valid prescription to participate in the program.

The standard starting dose for Zepbound is $349 per month, while higher doses are $499 per month.

Sam’s Club, Costco, and CVS Are Offering Discounted GLP-1s, Too

Other retailers are also offering deals on GLP-1s for people who don’t have prescription insurance coverage or who have been denied coverage for the drugs.

The warehouse-club chain Sam’s Club (owned by Walmart) now offers a month’s supply of the semaglutide GLP-1s Ozempic and Wegovy for $499 through the use of Novo Nordisk copay cards. Same-day home delivery is $12 for club members, and free for Sam’s Club Plus Members.

Costco offers the same deal to members: $499 for a one-month supply at out-of-pocket pricing, as does the pharmacy chain CVS.

Those monthly prices are roughly half of what many people paid out of pocket before discounts, about $1,000 or more per month.

GLP-1s Are Lowering the Percentage of Americans With Obesity

The number of people using a GLP-1 is on the rise: A recent Gallup survey found that about 1 in 8 respondents (12.4 percent) reported taking a drug like Wegovy or Zepbound, compared with fewer than 6 percent just 18 months ago.

According to the same poll, the percentage of adults with obesity has also dropped to 37 percent, down from a record high of 39.9 percent in 2022. Although that may not seem like a lot, it translates to about 7.6 million fewer adults with obesity.

Cash-Pay Is Still the Only Way Many People Can Get GLP-1s

Insurance issues mean that even people with obesity who could see a significant health boost from GLP-1s may find they have to pay out of pocket.

For people with insurance coverage, there are usually multiple hoops to jump through, and each insurance company’s prior authorization requirements are different, says Allison Rhodes, MD, an internal medicine and obesity medicine physician at the Ohio State University Wexner Medical Center in Columbus.

“Some insurance companies list GLP-1 medications used ‘for weight loss’ as a coverage exclusion, which means that even if a patient meets FDA-approved criteria and would benefit from using the medication, the plan will not pay for the medication,” she says.

That means that even with an obesity diagnosis and a prescription, people will have to pay for the GLP-1 out of pocket.

More people may find themselves needing to self-pay for GLP-1s in 2026 as more insurance companies plan to stop covering the medications for weight loss.

“There are many insurances that have moved toward not having weight loss management as part of their coverage,” leaving many patients to cover the costs out of pocket, says Ackah.

GLP-1s Are More Affordable Now — but Is It Enough?

The ability to buy or pick up discounted GLP-1s at outlets like Walmart, Costco, Sam’s Club, and CVS could make GLP-1s more affordable for some people who don’t have insurance coverage, says Sarah Ackah, MD, MPH, an endocrinologist also at the Ohio State University Wexner Medical Center.

“Having the program run directly through the pharmacy is also more convenient and efficient, as individuals can talk to their pharmacist and find out the cheapest cost for them,” says Dr. Ackah.

While $349 to $499 a month is an improvement on the previous list prices, affordability remains a barrier for many patients, she says. For a person taking the standard dose, a year’s supply would cost $6,000.

Discount GLP-1 Prices: Walmart, Costco, Sam’s Club, CVS

Keep in mind you still need a prescription for any GLP-1 medication.

Walmart

  • Zepbound vials via LillyDirect pickup: $349 a month for the 2.5 mg starting dose; $499 a month for higher doses when program criteria are met. This form of Zepbound comes in a vial, which means patients must use a disposable syringe to inject it, rather than a self-injectable pen.

Costco

  • Wegovy and Ozempic self-injectable pens: $499 a month at out-of-pocket pricing. (Membership perks may add cash-back rewards through some plans.)

Sam’s Club

  • Wegovy or Ozempic self-injectable pens: $499 a month for a one-month supply at out-of-pocket pricing.

CVS

  • Wegovy or Ozempic self-injectable pens: $499 a month for a one-month supply at out-of-pocket pricing.


EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. LillyDirect and Walmart Pharmacy Launch First Retail Pick-Up Option with Direct-to-Consumer Pricing for Zepbound. Lilly News Release. October 29, 2025.
  2. Sam’s Club Members Now Get Free Same-Day Delivery of Refrigerated Medications, Including GLP-1s. Sam’s Club Press Release. October 6, 2025.
  3. Costco to Sell Ozempic and Wegovy at a Large Discount for People Without Insurance. NBC News. October 3, 2025.
  4. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans. KFF. June 12, 2024.
  5. Obesity Rate Declining in the U.S. Gallup. October 28, 2025.
  6. Weight Loss Drugs Are Bringing Down the Country’s Obesity Rate, a Survey Shows. NPR Shots. October 28, 2025.
  7. Blue Cross Blue Shield of Massachusetts Will Stop Covering Popular Drugs Weight Loss. Here’s Why. CBS News. April 18, 2025.
  8. CVS Strikes a Deal to Offer Wegovy at a Discount. Fortune. May 1, 2025.

Emily Kay Votruba

Fact-Checker
Emily Kay Votruba has copy edited and fact-checked for national magazines, websites, and books since 1997, including Self, GQ, Gourmet, Golf Magazine, Outside, Cornell University Press, Penguin Random House, and Harper's Magazine. Her projects have included cookbooks (Padma Lakshmi's Tangy Tart Hot & Sweet), self-help and advice titles (Mika Brzezinski's Know Your Value: Women, Money, and Getting What You're Worth), memoirs (Larry King's My Remarkable Journey), and science (Now You See It: How the Brain Science of Attention Will Transform How We Live, Work, and Learn, by Cathy Davidson). She started freelancing for Everyday Health in 2016.
Becky Upham, MA

Becky Upham

Author

Becky Upham has worked throughout the health and wellness world for over 25 years. She's been a race director, a team recruiter for the Leukemia and Lymphoma Society, a salesperson for a major pharmaceutical company, a blogger for Moogfest, a communications manager for Mission Health, a fitness instructor, and a health coach.

Upham majored in English at the University of North Carolina and has a master's in English writing from Hollins University.

Upham enjoys teaching cycling classes, running, reading fiction, and making playlists.